Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Tax experts and pharmaceutical executives have said that tariffs would be at best a blunt instrument for discouraging corporate activity in Ireland.
Simplified Text
Tax experts pharmaceutical executives said tariffs would be a blunt instrument for discouraging corporate activity in Ireland.
Confidence Score
0.900
Claim Maker
Tax experts and pharmaceutical executives
Context Type
News Article
Context Details
{
    "topic": "Tariffs",
    "industry": "Pharmaceutical",
    "location": "Ireland"
}
Subject Tags
Business Economic Tax
UUID
9fdb5dbd-ac68-4af8-99b0-ea4a79536ffe
Vector Index
✗ No vector
Created
September 12, 2025 at 2:46 AM (1 day ago)
Last Updated
September 12, 2025 at 2:46 AM (1 day ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337
Tariffs Set to Hit Ireland, Where U.S. Drugmakers Play Tax Games
Pending
News
41 claims 🔥
1 day ago
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337

US drugmakers using Ireland for tax advantages face billions in tariffs from planned 15% levy on European medicines. Companies may shift production to the US, incurring increased costs.

Pharmaceutical Industry
International Trade
Taxation
Ireland
United States
Tariffs
Corporate Tax Avoidance

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP